Ronald Kamdem Analyst PerformanceManaging Director, Head of US REITs and CRE Research at Morgan StanleyRonald Kamdem is a stock analyst at Morgan Stanley focused in the finance sector, covering 17 publicly traded companies. Over the past year, Ronald Kamdem has issued 25 stock ratings, including buy, hold, and sell recommendations. While full access to Ronald Kamdem's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ronald Kamdem's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings26 Last 3 YearsBuy Recommendations38.46% 10 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution26RatingsDistribution of strong buy, buy, hold, and sell ratings by Ronald Kamdem.RatingPercentageCount Strong Buy0.0%0 ratings Buy38.5%10 ratings Hold53.8%14 ratings Sell7.7%2 ratingsOut of 26 total stock ratings issued by Ronald Kamdem at Morgan Stanley, the majority (53.8%) have been Hold recommendations, followed by 38.5% Buy and 7.7% Sell.Best & Worst CallsBest Call000.0%ADCJul 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE82.4% of companies on NYSE14 companiesNASDAQ17.6% of companies on NASDAQ3 companiesRonald Kamdem, an analyst at Morgan Stanley, currently covers 17 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageFinance16 companies94.1%Medical1 company5.9%Ronald Kamdem of Morgan Stanley specializes in stock coverage within the Finance sector, with additional focus on Medical companies.Coverage IndustriesIndustryPercentageREIT - EQTY TRUST - OTHER10 companies58.8%REIT - EQTY TRUST - RETAIL5 companies29.4%REAL ESTATE OPS1 company5.9%NURSING & PERSONAL CARE FACILITIES1 company5.9% Ronald Kamdem's Ratings History at Morgan Stanley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsUEUrban Edge Properties9/24/2025Boost Price Target$19.98$21.00Equal Weight$0.0000.00% ROILINELineage9/22/2025Lower Price Target$40.37$46.00Equal Weight$0.0000.00% ROISPGSimon Property Group9/11/2025Boost Price Target$180.06$180.00Equal Weight$0.0000.00% ROIFVRFrontView REIT7/11/2025Downgrade$12.13$13.50Equal Weight$0.0000.00% ROIVICIVICI Properties7/8/2025Boost Price Target$32.94$35.00Equal Weight$0.0000.00% ROILINELineage6/23/2025Downgrade$44.76$50.00Equal Weight$0.0000.00% ROICBRECBRE Group6/12/2025Reiterated Rating$136.03$170.00Overweight$0.0000.00% ROISNDAShanda Interactive Entertainment5/20/2025Boost Price Target$25.91$26.00Equal Weight$0.0000.00% ROIAHRAmerican Healthcare REIT5/20/2025Boost Price Target$35.38$45.00Overweight$0.0000.00% ROIWELLWelltower5/6/2025Boost Price Target$150.93$160.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CURBCurbline Properties4/24/2025Lower Price Target$23.22$26.00Equal Weight$0.0000.00% ROICBRECBRE Group4/24/2025Lower Price Target$126.06$160.00Overweight$0.0000.00% ROIHPPHudson Pacific Properties4/15/2025Reiterated Rating$2.21$1.75Underweight$0.0000.00% ROIPLDPrologis4/14/2025Lower Price Target$102.33$120.00Outperform$0.0000.00% ROIMACMacerich4/1/2025Lower Price Target$17.12$19.00Equal Weight$0.0000.00% ROILINELineage4/1/2025Lower Price Target$56.90$75.00Overweight$0.0000.00% ROIAHRAmerican Healthcare REIT3/25/2025Boost Price Target$30.28$37.00Overweight$0.0000.00% ROIPGREParamount Group3/18/2025Lower Price Target$4.13$4.00Equal Weight$0.0000.00% ROIHPPHudson Pacific Properties3/18/2025Lower Price Target$2.98$2.25Underweight$0.0000.00% ROIVNOVornado Realty Trust3/14/2025Boost Price Target$36.61$28.00Equal Weight$0.0000.00% ROICBRECBRE Group2/19/2025Boost Price Target$142.00$165.00Overweight$0.0000.00% ROICURBCurbline Properties1/29/2025Initiated Coverage$25.27$27.00Equal Weight$0.0000.00% ROICBRECBRE Group1/15/2025Upgrade$124.82$160.00Overweight$0.0000.00% ROIMACMacerich1/15/2025Upgrade$19.43$20.00Equal Weight$0.0000.00% ROIGLPIGaming and Leisure Properties1/15/2025Downgrade$46.91$53.00Equal Weight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
